Published in J Exp Med on March 17, 1997
MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res (1998) 2.02
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest (2003) 1.32
Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J Exp Med (1998) 1.11
pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH. J Exp Med (1999) 1.08
Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms. BMC Bioinformatics (2007) 1.05
Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin Exp Immunol (2003) 0.97
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis. BMC Immunol (2012) 0.93
A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11. Proc Natl Acad Sci U S A (1999) 0.81
Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone. J Biomed Biotechnol (2003) 0.79
Peptide-binding motifs of the mixed haplotype Abetaz/Aalphad major histocompatibility complex class II molecule: a restriction element for auto-reactive T cells in (NZBxNZW)F1 mice. Immunology (1998) 0.77
GPS-MBA: computational analysis of MHC class II epitopes in type 1 diabetes. PLoS One (2012) 0.77
Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells. J Autoimmun (2013) 0.76
Immunology of IDDM. Diabetologia (1997) 0.76
The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains? Proc Natl Acad Sci U S A (1999) 0.76
MHC ligands and peptide motifs: first listing. Immunogenetics (1995) 7.78
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (1993) 5.47
Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas. Proc Natl Acad Sci U S A (1982) 3.41
The murine autoimmune diabetes model: NOD and related strains. Adv Immunol (1992) 2.80
The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci U S A (1987) 2.77
Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A (1996) 2.21
Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol (1995) 2.15
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med (1995) 2.02
The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol (1996) 1.87
Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.51
Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci U S A (1996) 1.42
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med (Berl) (1997) 1.41
Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol (1991) 1.41
Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med (1993) 1.19
Overview: the major histocompatibility complex and insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab (1991) 1.11
Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol (1994) 1.07
Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides. J Exp Med (1995) 1.02
Breaking self-tolerance in nonobese diabetic mice. J Exp Med (1996) 1.02
Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells. J Immunol (1991) 0.98
Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J Exp Med (1993) 0.94
Defining rules for the peptide-MHC class II interaction. Curr Opin Immunol (1994) 0.94
Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules. Immunogenetics (1993) 0.93
Antigen recognition and peptide-mediated immunotherapy in autoimmune disease. Immunol Rev (1990) 0.90
Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Diabetologia (1993) 0.85
Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. J Autoimmun (1994) 0.82
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol (2000) 3.82
Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet (1993) 3.38
Turnover of carbon isotopes in tail hair and breath CO2 of horses fed an isotopically varied diet. Oecologia (2004) 3.14
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol (2001) 2.75
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med (1995) 2.29
Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23
Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol (2003) 2.14
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med (1995) 2.02
HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 1.99
Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res (1989) 1.97
Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev (1978) 1.91
ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res (2004) 1.88
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol (2001) 1.82
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med (1994) 1.81
Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics (1998) 1.77
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today (2000) 1.77
Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J (1996) 1.74
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Capacity of intact proteins to bind to MHC class II molecules. J Immunol (1989) 1.63
Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med (1996) 1.61
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60
DNA analysis in juvenile Huntington disease. Eur J Pediatr (1989) 1.58
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med (1999) 1.58
White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study. J Hypertens (1998) 1.58
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med (1996) 1.58
Gamma globulin and maternal rubella. Med J Aust (1973) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
A follow-up report of occupational stress in urban EMT-paramedics. Ann Emerg Med (1989) 1.54
The control of T cell responses by dendritic cell subsets. Curr Opin Immunol (2000) 1.53
The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today (1995) 1.51
Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med (1996) 1.50
Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen. Am J Transplant (2013) 1.50
Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol (1998) 1.49
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Parents of Children with Asperger Syndrome: What is the Cognitive Phenotype? J Cogn Neurosci (1997) 1.44
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
The fine specificity of regulatory T cells. IV. Idiotypic complementarity and antigen-bridging interactions in the anti-lysozyme response. Eur J Immunol (1979) 1.42
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol (1999) 1.42
SCORPION, a molecular database of scorpion toxins. Toxicon (2002) 1.40
Lysozyme-induced T-suppressor cells and antibodies have a predominant idiotype. Nature (1979) 1.40
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37
Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol (2000) 1.33
IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol (1997) 1.31
IL-12: a key cytokine in immune regulation. Immunol Today (1996) 1.31
A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem (2001) 1.30
Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry (1996) 1.29
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol (2001) 1.29
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol (2000) 1.28
Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol (1998) 1.28
Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med (1995) 1.28
HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens (2003) 1.28
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res (2000) 1.26
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Efficient immune responses in mice lacking N-region diversity. Eur J Immunol (1995) 1.22
Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol (1998) 1.22
Subcellular localization of myosin V in nerve growth cones and outgrowth from dilute-lethal neurons. J Cell Sci (1997) 1.21
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol (1995) 1.19
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells. Proc Natl Acad Sci U S A (2000) 1.19
Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med (1993) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology (2008) 1.18
Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg (2001) 1.16
Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol (1999) 1.14
Prediction of class I T-cell epitopes: evidence of presence of immunological hot spots inside antigens. Bioinformatics (2004) 1.13
Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol (1998) 1.13
Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction. EMBO J (1997) 1.12
Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis (2010) 1.12
Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest (1992) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol (1997) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Ethnicity is a significant factor in the epidemiology of rubella and Hodgkin's disease. Nature (1974) 1.09
IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol (1998) 1.09
Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol (1989) 1.09
Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther (2004) 1.08
Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis Rheum (1997) 1.08
Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol (2007) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07